Use of growth hormone in low dose

Details for Australian Patent Application No. 2006200127 (hide)

Owner Pfizer Inc.

Inventors Dunger, David B

Agent Davies Collison Cave

Pub. Number AU-B-2006200127

Parent 2001239635

Filing date 12 January 2006

Wipo publication date 2 February 2006

Acceptance publication date 25 October 2007

International Classifications

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

2 February 2006 Application Open to Public Inspection

  Published as AU-B-2006200127

2 February 2006 Complete Application Filed

11 October 2007 Change of Name(s) of Applicant(s), Section 104

  Pharmacia AB The name of the applicant has been changed to Pfizer Inc.

25 October 2007 Application Accepted

  Published as AU-B-2006200127

6 March 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006200128-Baking device especially for self-service shops

2006200126-Flow rate controller